| Azerbaijão | Turki | Austria | |
| Transplantasi sumsum tulang alogenik dari donor tidak sedarah | - | dari $71,500 | dari $180,000 |
| Transplantasi sumsum tulang allogenik dari donor terkait | - | dari $53,500 | dari $150,000 |
| Transplantasi sumsum tulang | - | dari $36,000 | dari $140,000 |
| Terapi sel T CAR | - | dari $150,000 | dari $350,000 |
| Terapi biologis | - | dari $5,500 | dari $20,000 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Hematologi Onkologi. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Hematologi Onkologi dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Hematologi Onkologi Anda.
Dr. Aydogdu berspesialisasi dalam deteksi dini kanker pediatrik, dengan fokus pada peningkatan hasil bagi pasien muda di Rumah Sakit Liv Bona Dea Baku.
Pasien yang menerima perawatan hematologi dan onkologi di Azerbaijan mungkin mengalami efek samping jangka pendek seperti kerontokan rambut dan kelelahan. Risiko jangka panjang meliputi neuropati perifer dan gangguan kognitif. Pusat-pusat terakreditasi, seperti Rumah Sakit Liv Bona Dea di Baku atau Pusat Onkologi Nasional, menyediakan dukungan multidisiplin untuk mengatasi masalah-masalah ini.
Opini ahli Bookimed: Rumah Sakit Baku Liv Bona merawat 200.000 pasien setiap tahun dan diakui oleh Bookimed sebagai rumah sakit terbaik untuk penyakit darah dan pengobatan kanker pada tahun 2019. Volume pasien yang tinggi ini memungkinkan dokter spesialis seperti Dr. Selim Aydogdu dan Dr. Tural Pashayev untuk menyempurnakan protokol perawatan suportif untuk kondisi kompleks seperti leukemia dan mieloma. Pasien harus memprioritaskan fasilitas medis yang terakreditasi JCI di Baku untuk memastikan kepatuhan terhadap standar keselamatan internasional saat menangani toksisitas.
Umpan balik pasien: Pasien mencatat bahwa kelelahan seringkali lebih parah dari yang diperkirakan dan tidak mudah hilang dengan istirahat. Mereka juga menekankan bahwa neuropati dan masalah memori dapat berlanjut lama setelah pengobatan berakhir, sehingga sangat penting untuk membahas risiko ini sedini mungkin.
Liv Bona Dea Hospital Baku and the National Center of Oncology are the leading facilities for haematology-oncology in Azerbaijan. These centres provide JCI-accredited care and integrated diagnostic laboratories. They specialise in treating blood cancers like leukaemia and lymphoma using immunotherapy and bone marrow transplantation.
Bookimed Expert Insight: Data shows Liv Bona Dea Hospital Baku consistently ranks as a top choice. While the National Center of Oncology has more beds, Liv Bona Dea prioritises shorter waiting times. This makes them more accessible for those travelling from abroad for urgent chemotherapy or biopsies.
Patient Consensus: Patients in Azerbaijan value hospitals that combine pathology, chemotherapy, and transfusion services. They often note that having specialist haematologists ensures clearer diagnostic staging and transparent treatment options.
Azerbaijan provides oncological care featuring bone marrow transplantation, immunotherapy, and targeted molecular therapies. JCI-accredited facilities in Baku, such as Liv Bona Dea Hospital Baku, use global protocols. Treatments include TrueBeam radiotherapy, HIPEC for abdominal cancers, and precision medicine for complex blood disorders.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku serves over 200,000 patients annually. It holds specific 2019 rankings for excellence in cancer and blood disorders. This high patient volume allows the facility to maintain 219 beds and 20 specialised departments. Australian patients can expect care that includes genetic tumour profiling and molecular testing.
Patient Consensus: Patients suggest confirming local diagnostic capacity and requesting English medical reports before travel. Experience shows that Baku facilities effectively coordinate complex multi-cycle regimens. They also provide dedicated international service desks.
Recommended haematologist-oncologists in Baku for international consultations include Dr Tural Pashayev and Dr Selime Aydogdu. They practise at the JCI-accredited Liv Bona Dea Hospital. These specialists provide care for adult and paediatric blood disorders. They use modern protocols for bone marrow transplants and cell therapy.
Bookimed Expert Insight: Baku has become a regional hub for haematology-oncology. Liv Bona Dea Hospital serves over 200,000 patients annually. In 2019, it received top rankings for blood disorder treatment. This high patient volume often means the medical teams have extensive experience. They handle complex cases like bone marrow failure and rare metabolic blood diseases.
Patient Consensus: Patients find the international support teams in Azerbaijan helpful. They appreciate that major facilities coordinate digital scan uploads. These teams also handle translations for overseas medical records.
Azerbaijan provides specialised treatment for blood disorders through dedicated centres and specialist clinics in Baku. Facilities like Liv Bona Dea Hospital Baku offer bone marrow transplantation, factor therapy, and iron chelation. The country manages these conditions through national healthcare programmes and regional haematology networks.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku stands out for international patients. It holds JCI accreditation. Bookimed patients ranked it as a top centre for blood disorder treatment. Public centres handle high local volume. However, this private facility integrates Turkish Medical Association standards. This makes it a preferred choice for those seeking private rooms.
Patient Consensus: Patients recommend verifying that hospitals have dedicated haematology services before travel. Those managing rare disorders emphasise confirming access to clotting factors. They also suggest coordinating care with tertiary centres in Baku.
Medical tourism for oncology in Baku is a rapidly growing regional sector. The city is a hub for haematology-oncology. It serves many patients from Central Asia and the CIS. Facilities like Liv Bona Dea Hospital Baku use Turkish medical partnerships and maintain JCI-accredited standards.
Bookimed Expert Insight: Baku has transitioned from a patient source to a regional treatment destination. Liv Bona Dea Hospital Baku now treats 200,000 patients annually across 20 departments. This volume allows the facility to provide diverse specialisations within a single centre. These range from adult haematology to paediatric cell therapy.
Patient Consensus: Patients value having access to Turkish clinical protocols in Azerbaijan. Large private hospitals in Baku are praised for their multidisciplinary approach to blood disorders and complex cancers.